Moreover, several studies demonstrated that Tregs derived from both blood and tumor of CRC patients were able to suppress the proliferation of autologous CD4 and CD8 T cells (47, 48), and that the frequency of Tregs was negatively correlated with the expression of IFN-γ and IL-2 in the tumors (49). Here, CD8A is linked to colorectal carcinoma.